Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tudor domain-containing protein 5 (TDRD5) is an RNA-binding protein that plays an essential role in germline development, retrotransposon repression, and piRNA-mediated gene silencing during spermatogenesis. It is required for proper assembly of chromatoid bodies and pi-bodies in male germ cells, and is crucial for the production and processing of pachytene piRNAs, which help prevent mobilization of transposable elements and protect genome integrity in germ cells[1][2][5]. Loss of TDRD5 disrupts piRNA biogenesis, transposon silencing, chromatoid body structure, and leads to spermatogenic arrest and infertility in males[1][2][5]. TDRD5 is expressed in germ cells of both testes and ovaries, though its most defined function is in spermatogenesis and male fertility[2][5]. No clinically approved drugs target TDRD5, and it is not currently considered a therapeutic target for somatic diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tudor domain-containing protein 5 (TDRD5).